Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASIS for GAMMAGARD in Primary Immunodeficiency
NCT02123615Phase 2Unknown
- Start
- Jan 2016
- Primary completion
- Jun 2016
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of polyvalent human immunoglobulin in primary immunodeficiency (PI). Status: unknown.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
primary immunodeficiency (PI)
Beyond the preview
Go deeper on NCT02123615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02123615.